Chimeric PSA enhancers exhibit augmented activity in prostate cancer gene therapy vectors

Gene Therapy

Volumn 8, Issue 18, 2001, Pages 1416-1426

  Wu, L ^a   Matherly, J ^a   Smallwood, A ^a   Adams, J Yeates ^a   Billick, E ^a   Belldegrun, A ^a   Carey, M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adenoviral vector; Androgen responsive element; Gene therapy; Prostate cancer; PSA promoter and enhancer; Tissue specificity

Indexed keywords

ANDROGEN RECEPTOR; LUCIFERASE; PROSTATE SPECIFIC ANTIGEN; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; BIOCHEMISTRY; CHIMERA; CONTROLLED STUDY; CORRELATION FUNCTION; CYTOMEGALOVIRUS; ENHANCER REGION; GENE CONSTRUCT; GENE TARGETING; GENE THERAPY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMAGING; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; RECEPTOR BINDING; SENSITIVITY AND SPECIFICITY; TISSUE SPECIFICITY; TUMOR XENOGRAFT;

ADENOVIRIDAE; ANIMALS; BASE SEQUENCE; ENHANCER ELEMENTS (GENETICS); GENE THERAPY; GENETIC VECTORS; HUMANS; MALE; MICE; MICE, SCID; MOLECULAR SEQUENCE DATA; NEOPLASM TRANSPLANTATION; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; RECOMBINANT FUSION PROTEINS; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 0034834392     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301549     Document Type: Article

References (53)

1. Cancer statistics, 1999
2. Species- and organ-specificity of secretory proteins derived from human prostate and seminal vesicles
3. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer
4. Tissue-specific and hormonal regulation of human prostate-specific glandular kallikrein
5. Prostate-specific antigen expression is regulated by an upstream enhancer
6. An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter
7. Identification of a positive regulatory element responsible for tissue-specific expression of prostate-specific antigen
8. The promoter of the prostate-specific antigen gene contains a functional androgen responsive element
9. Prostate tissue specificity of the prostate-specific antigen promoter isolated from a patient with prostate cancer
10. Two androgen response regions cooperate in steroid hormone regulated activity of the prostate-specific antigen promoter
11. Identification of two novel cis-elements in the promoter of the prostate-specific antigen gene that are required to enhance androgen receptor-mediated transactivation
12. Human androgen receptor binding to the androgen response element of prostate specific antigen
13. A 6-kb promoter fragment mimics in transgenic mice the prostate-specific and androgen-regulated expression of the endogenous prostate-specific antigen gene in humans
14. Transgenic mice carrying a PSArasT24 hybrid gene develop salivary gland and gastrointestinal tract neoplasms
15. Tissue-specific expression of the human prostate-specific antigen gene in transgenic mice: Implications for tolerance and immunotherapy
16. Cooperative assembly of androgen receptor into a nucleoprotein complex that regulates the prostate-specific antigen enhancer
17. Development of a new plasmid vector with PSA-promoter and enhancer expressing tissue-specificity in prostate carcinoma cell lines
18. Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines
19. Development of prostate-specific antigen promoter-based gene therapy for androgen-independent human prostate cancer
20. In vivo expression of prostate-specific adenoviral vectors in a canine model
21. In situ gene therapy for adenocarcinoma of the prostate: A phase I clinical trial
22. Prostate attenuated replication competent adenovirus (ARCA) CN706: A selective cytotoxic for prostate-specific antigen-positive prostate cancer cells
23. Two classes of androgen receptor elements mediate cooperativity through allosteric interactions
24. ALY, a context-dependent coactivator of LEF-1 and AML-1, is required for TCR alpha enhancer function
25. The enhanceosome and transcriptional synergy
26. Reversal of intrinsic DNA bends in the IFN beta gene enhancer by transcription factors and the architectural protein HMG I(Y)
27. Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome
28. Androgen-induced inhibition of proliferation in human breast cancer MCF7 cells transfected with androgen receptor
29. Techniques for human adenovirus vector construction and characterization
30. Human renal carcinoma line transfected with interleukin-2 and / or interferon alpha gene(s): Implications for live cancer vaccines
31. Intratumoral administration of adenoviral interleukin 7 gene-modified dendritic cells augments specific antitumor immunity and achieves tumor eradication
32. Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice
33. Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgen-dependent tumors through a two-step process
34. Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice
35. Activation of RNA polymerase II transcription
36. Multiple hepatocyte-enriched nuclear factors function in the regulation of transthyretin and α1-antitrypsin genes
37. PDEF, a novel prostate epithelium-specific ets transcription factor, interacts with the androgen receptor and activates prostate-specific antigen gene expression
38. Selective activation of the probasin androgen responsive region by steroid hormones
39. Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: Construction and testing of a tissue-specific adenovirus vector
40. A helper-dependent adenovirus vector system: Removal of helper virus by Cre-mediated excision of the viral packaging signal
41. Strategies to adapt adenoviral vectors for targeted delivery
42. Nonviral vectors in the new millennium: Delivery barriers in gene transfer
43. Androgen receptor gene amplification: A possible molecular mechanism for androgen deprivation therapy failure in prostate cancer
44. Androgen-independent induction of prostate-specific antigen gene expression via cross-talk between the androgen receptor and protein kinase A signal transduction pathways
45. A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signalling by the HER-2/neu tyrosine kinase
46. Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor
47. Imaging of adenoviral directed herpes simplex virus type 1 thymidine kinase gene expression in mice with ganciclovir
48. Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography
49. Adenovirus-mediated transfer of the muscle glycogen phosphorylase gene into hepatocytes confers altered regulation of glycogen metabolism
50. Selective extraction of polyoma DNA from infected mouse cell cultures
51. An adenovirus Epstein-Barr virus hybrid vector that stably transforms cultured cells with high efficiency
52. A simple technique for the recue of early region I mutations into infectious human adenovirus type 5
53. Eukaryotic gene transcription with purified components